← feed

Is NCT03118349 results overdue?

Yes — results are overdue. Primary completion was 2018-04-11; the FDAAA-801 reporting deadline (2019-04-11) passed 2674 days ago and no results are posted on ClinicalTrials.gov.

Study of 177Lu Human Monoclonal Antibody 5B1 (MVT-1075) in Combination With a Blocking Dose of MVT-5873 as Radioimmunotherapy

NCT IDNCT03118349 ↗
SponsorBioNTech Research & Development, Inc. (INDUSTRY)
PhasePHASE1
StatusTERMINATED
Primary completion2018-04-11 (ACTUAL)
Reporting deadline2019-04-11 (completion + 365d)
Days overdue2674
Results postedNo — check results tab ↗
FDA-regulateddrug: yes, device: no
ProvenanceFlagged overdue on 2026-06-21 · SHA-256 92b075b8472073d2… (hash-chained, tamper-evident)

Source of record: ClinicalTrials.gov NCT03118349. The reporting requirement is FDAAA 801 (Public Law 110-85 §801) and the Final Rule, 42 CFR Part 11.

⚠ Public-record facts from ClinicalTrials.gov — not a finding of violation, fraud, or non-compliance, and not legal or investment advice. Full disclaimer →